Elevance Health, Inc. financials
Key figures from Elevance Health, Inc.'s filings with the U.S. Securities and Exchange Commission: the latest quarter against a year earlier, and the trend across recent quarters and fiscal years.
Latest quarter vs a year earlier
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | $51.4B | $50.7B | +1.4% |
| Net income | $1.4B | $1.2B | +14.8% |
| Free cash flow | $1.0B | $775M | +29.0% |
| Gross margin | 89.0% | 89.4% | -0.4 pts |
| Operating margin | 2.5% | 2.6% | -0.1 pts |
| Net margin | 2.7% | 2.3% | +0.3 pts |
Quarterly trend
Fiscal years
| Fiscal year | Revenue | Net income | Net margin | Free cash flow | EPS (diluted) |
|---|---|---|---|---|---|
| FY Dec 2025 | $199.1B | $5.7B | 2.8% | $3.2B | $25.21 |
| FY Dec 2024 | $177.0B | $6.0B | 3.4% | $4.6B | $25.68 |
| FY Dec 2023 | $171.3B | $6.0B | 3.5% | $6.8B | $25.22 |
| FY Dec 2022 | $156.6B | $5.9B | 3.8% | $7.2B | $24.28 |
| FY Dec 2021 | $138.6B | $6.2B | 4.4% | $7.3B | $24.95 |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters. All figures from company filings with the SEC.